Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating micafungin for invasive candidiasis or candidemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Astellas Pharma China, Inc. | Conditions: Candidemia, Candidiasis | Phase 4 | Status: TERMINATED